On behalf of the Organizing Committee, I invite you to register and attend this important scientific conference taking place over two days. The conference brings together leading scientists from across cancer genomics and rare disease for a unique opportunity to interact and integrate.
Leading on from the successful conference we held last year, we were encouraged to repeat our efforts to organize this targeted educational conference. Our intention is to deliver a rich and interesting program with a broad range of topics designed to be of interest to healthcare professionals from various disciplines.
The focus for 2019 is on oncology with particular focus on Breast Cancer, Uro-Oncology Head & Neck cancers and Rare Diseases, including rare skin cancers, and genomics, as well as a review of new imaging techniques.
The topic of Rare disease also reflects the close collaboration between Hamad Medical Corporation and Heidelberg University, who have shared knowledge and expertise in this, among other, subject for many years. I am therefore delighted that the caliber of our speakers is once again outstanding. The speakers, who come from both organizations, will deliver a range of lectures and presentations designed to promote learning and scientific knowledge among doctors, nurses, researchers and academics.
Our aim is to continue making this an exceptional event for all healthcare professionals interested in Rare disease, oncology and related scientific research. We hope you will use this learning as a platform for professional development, extensive clinical and scientific discussions, and to promote professional networking with peers.
The conference will facilitate peer-to-peer dialogue and promote new collaboration between attendees from all participating organizations.
We look forward to your active and engaging participation.
Dr. Saad Al Kaabi
Chairman, International Medical Affairs Office, HMC